GLP-1 receptor agonists and hospitalization due to infections in patients with type 2 diabetes: A nationwide cohort study
{{output}}
Aims: Glucagon-like peptide 1 receptor agonists (GLP-1RAs) demonstrate pleiotropic effects, notably encompassing anti-inflammatory properties. We aim to compare the association of GLP-1RAs versus dipeptidyl peptidase-4 inhibitors... ...
